The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on November 10, 2026

23 minutes ago

Tomo Marjanovic to Address Longevity and Medical Tourism in the Gulf at Forbes Middle East Summit

Indeterminate EIN Presswire

32 minutes ago

Palisade Bio Reports Third Quarter 2026 Financial Results and Advances PALI-2108 Phase 2 Clinical Development Programs

Indeterminate GlobeNewswire

36 minutes ago

Anaptys Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

40 minutes ago

Context Therapeutics Reports Third Quarter 2026 Financial Results and Pipeline Progress

Indeterminate GlobeNewswire

41 minutes ago

Eupraxia Pharmaceuticals Establishes At-The-Market Offering Program

Indeterminate GlobeNewswire

42 minutes ago

Precipio Announces Q3-2026 Financial Results

Indeterminate GlobeNewswire

42 minutes ago

BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

42 minutes ago

Spectral AI Announces 2026 Third Quarter Financial Results

Indeterminate GlobeNewswire

an hour ago

Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates

Indeterminate GlobeNewswire

an hour ago

Biomea Fusion Reports Third Quarter 2026 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

an hour ago

Autolus Therapeutics Presents Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

an hour ago

NextCure Provides Business Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Fortress Biotech Announces an Exclusive License Agreement for FB-607 for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D)

Indeterminate GlobeNewswire

an hour ago

Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance

Indeterminate GlobeNewswire

an hour ago

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

an hour ago

PetMeds® Announces Second Quarter Financial Results

Indeterminate GlobeNewswire

an hour ago

Bionano Reports Third Quarter 2026 Results and Provides a Business Update

Indeterminate GlobeNewswire

an hour ago

Capricor Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

an hour ago

Metagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Prime Medicine Announces Proposed $125.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire